Improving the Tumor Sequencing & Neoantigen Discovery to Develop More Targeted Personalized Cancer Vaccines
Overcoming the Manufacturing Scale-Out Challenge of Personalized Cancer Vaccines to Deliver Therapies to Patients Faster
Spotlighting Design & Synthesis Strategies to Manufacture High Quality Personalized Cancer Vaccines on a Rapid Timescale to Obtain a Strong Immune Response
Assessing the Cost, Speed, & Viability of Personalized Cancer Vaccines to Develop Targeted Therapies for More Patients
Spotlighting Breakthrough Clinical Success for Personalized Cancer Vaccines Toward the Next Best Approval
Exploring Computational Methods to Identify the Relevant Antigens & Neoantigens to Find the Best Targets for Personalized Cancer Vaccines
Advancing Development of DNA-Based Cancer Vaccines for Maximum Neoantigen Expression & Immune Response
Discovering Other Modalities in Cancer Vaccines for Increased Safety, Targeted Delivery, & More Effective Vaccines
Supercharging the Development of Personalized Cancer Vaccines by Overcoming Regulatory Challenges in the Clinic to Achieve Market Approval
Unlocking Personalized Vaccine Development for Different Indications of Cancer to Induce an Immune Response to Shrink the Tumor
Uncovering Best Strategies With Clinical Trial Design, Regualtions, & Combination Therapies to Achieve Efficacy
Probing into the Best Delivery Methods to Achieve Targeted Individualized Vaccines
Venue
Hilton Boston Back Bay ,
40 Dalton Street, Boston, Massachusetts, United States
